A critical breakthrough in cancer study is emerging with the use of mini-antibodies to restore damaged p53. This crucial malignant suppressor protein is frequently disabled in various forms of tumors, resulting https://thebookmarkid.com/story22063493/mini-antibodies-revive-p53-the-promising-pathway-for-tumor-management